Perthera AI

Our proprietary proven Therapeutic Intelligence Engine is built over a of decade with 10 Databases which are updated daily, 50,000+ Heuristic Rules & Algorithms, Artificial Intelligence & Machine Learning. It is designed to utilize patient medical, treatment and molecular information to precisely match patients to therapy options best tailored to their unique cancer types. The Engine utilizes the medical world’s depth of knowledge by incorporating published clinical research and active clinical trials, as well as all FDA-approved treatments options, in its analysis of a patient’s unique tumor profile.

Perthera’s Therapeutic Intelligence Engine

The Perthera Therapeutic Intelligence Engine is Perthera’s advanced system that combines Artificial Intelligence with computational learning to generate patient-matched treatment recommendations for the Perthera Report..

For every patient, the Therapeutic Intelligence Engine integrates:

  • The patient’s multi-omic tumor profile
  • Medical and treatment history
  • Perthera’s database of Real-World outcomes
  • Most recent published cancer research
  • NCCN guidelines
  • All FDA-approved therapy options
  • Actively Enrolling Clinical Trial Options

 

Once the Therapeutic Intelligence Engine combines all of this data to generate treatment recommendations for a patient, Perthera’s Molecular Tumor Board assesses and approves the Perthera Report for quality assurance before it is sent off to the ordering physician.

 

The use of the Perthera Precision Oncology Platform has achieved significant results in a number of cancer types. Nearly 50% of the resected cancer patients analyzed by the Perthera Precision Oncology Platform to date have had “actionable mutations”, meaning that 1 in 2 patients analyzed had tumors with mutations that could be treated with targeted molecular therapies.

The Perthera Therapeutic Intelligence Engine is Perthera’s advanced system that combines Artificial Intelligence with computational learning to generate patient-matched treatment recommendations for the Perthera Analysis.

For every patient, the Therapeutic Intelligence Engine integrates:

  • The patient’s multi-omic tumor profile
  • Medical and treatment history
  • Perthera’s database of Real-World outcomes
  • Most recent published cancer research
  • NCCN guidelines
  • All FDA-approved therapy options
  • Actively Enrolling Clinical Trial Options


Once the Therapeutic Intelligence Engine combines all of this data to generate treatment recommendations for a patient, Perthera’s Molecular Tumor Board assesses and approves the Perthera Analysis for quality assurance before it is sent off to the ordering physician.